See the factory by live video walkthrough
Book an on-site factory visit in GuangzhouLaunching a body acne wash in the U.S. market means stepping into the FDA’s over‑the‑counter (OTC) drug world. Unlike regular cleansers, a product that treats acne is legally a drug, even if it feels…
Launching a body acne wash in the U.S. market means stepping into the FDA’s over‑the‑counter (OTC) drug world. Unlike regular cleansers, a product that treats acne is legally a drug, even if it feels like a cosmetic. For brands and private‑label buyers, the path to a compliant product runs through three non‑negotiables: using only monograph‑approved active ingredients, packaging with a precise Drug Facts label, and manufacturing in an FDA‑registered facility that follows drug GMPs. This guide walks you through the essential rules so you can avoid red‑label rejections and get to market faster.
Any cleanser marketed to “treat acne,” “clear breakouts,” or “fight pimples” is automatically classified as an OTC drug in the United States. The FDA’s final monograph for acne drug products defines what actives you can use, their allowable concentrations, and the exact labeling you must print on every package. There is no separate FDA approval required before selling, but you must follow the monograph to the letter. If your formula uses an active outside the monograph or makes an unapproved claim, the product is considered an unapproved new drug and can be subject to enforcement action.
Only specific actives are legally recognized for OTC acne treatment. For a rinse‑off body wash, the most practical options are:
| Active Ingredient | Allowed Concentration | Purpose in a Body Wash |
|---|---|---|
| Salicylic Acid | 0.5% – 2.0% | Exfoliates pores, helps prevent new breakouts |
| Benzoyl Peroxide | 2.5% – 10.0% | Kills acne‑causing bacteria, reduces oil |
| Sulfur | 3.0% – 10.0% | Dries and peels away dead skin cells |
Resorcinol and resorcinol monoacetate are also monograph actives, but they are rarely used in modern formulations and are more common in leave‑on products. Always confirm your chosen active and concentration against the current Final Monograph for OTC Acne Drug Products (21 CFR Part 333).
The Drug Facts panel is the legal, standardized information box required on all OTC drug products. For a body acne wash, the panel must include, in this exact order:
The panel must follow a specific graphical format — bulleted text, bold headings, a horizontal line separating the sections. Small packages may use a simplified linear format, but the content is identical. Do not add marketing claims inside the Drug Facts box; it is a regulatory element, not a selling space.
Your manufacturer must operate under drug Good Manufacturing Practices (GMPs) as defined in 21 CFR Part 211. Practically, this means:
When vetting a contract manufacturer, ask for their FDA establishment registration number, recent GMP inspection history, and examples of Drug Facts panels they have prepared for other acne washes. A factory that has never produced an OTC drug will likely underestimate the documentation and testing burden.
Many first‑time buyers stumble on seemingly small details that have big regulatory consequences. Watch for these:
No. OTC drugs that comply fully with the applicable monograph do not require pre‑market FDA approval. However, the product must be manufactured in an FDA‑registered facility, follow drug GMPs, and be properly listed. If your formula deviates from the monograph (different active, new indication), you would need to file a New Drug Application.
You cannot replace a monograph active with an unapproved ingredient and still claim “acne treatment.” Tea tree oil may be listed as an inactive ingredient, but the product must contain one of the recognized actives at the right concentration to treat acne. Making an acne claim without a monograph active turns your product into an unapproved new drug.
A regular body wash is a cosmetic that cleanses the skin. It can claim “deep cleansing” or “refreshes,” but cannot say it treats acne. Once you add a monograph active and label it for acne, it becomes a drug and must carry the Drug Facts panel. The entire regulatory posture shifts from cosmetic to drug, even if the formula feels identical except for the active.
Yes. Each distinct product — different active concentration, different active ingredient, different packaging size — requires its own NDC number. If you sell a 2% salicylic acid wash in an 8‑oz tube and a 12‑oz bottle, those are two separate listings.
You can, but the labeling must reflect the intended uses. If you market it for body acne, the directions and warnings should match that use. The active ingredient and concentration stay the same. Just be careful that the front panel claims don’t create a new intended use that falls outside the monograph (for example, “treats back acne fast” is okay; “cures cystic acne” is not).
Ready to develop a compliant, market‑ready body acne wash? Request a Quote to start the formulation and labeling review with our team.